Amprius Technologies (AMPX) Stock Valuation After Drone Battery Deal And Short Seller Scrutiny

Why Amprius Technologies Stock Is Back in Focus

Amprius Technologies (AMPX) is drawing attention after announcing a collaboration to supply silicon anode lithium-ion batteries for Matternet’s M2 delivery drones, while also facing short seller allegations about its reported orders and disclosures.

See our latest analysis for Amprius Technologies.

Recent volatility has been sharp, with the share price falling 4.62% in the last session, 17.17% over the week and 12.73% over 90 days. At the same time, the year-to-date share price return is 86.61% and the 1-year total shareholder return is very large. This suggests that earlier momentum is now cooling as the Matternet deal and short seller claims recalibrate expectations and perceived risk.

If you are watching how battery and drone stories are moving, it can be useful to widen your radar and review 48 AI infrastructure stocks

So with Amprius sitting on strong year to date gains, alongside a recent pullback and analysts’ targets above the current US$16.31 share price, is this a genuine mispricing or is the market already banking on future growth?

Most Popular Narrative: 15.3% Undervalued

The most followed narrative currently places Amprius Technologies' fair value at $19.25 per share, above the recent $16.31 close, framing the stock as undervalued against its cash flow potential using a 9.26% discount rate.

The industry's increasing need for lightweight, high-energy-density battery solutions (for drones, electric aviation, and next-gen vehicles) enables Amprius to maintain premium pricing and outperform on gross and net margins due to its demonstrated product performance advantages, evidenced by record energy density and recent customer wins (e.g., AALTO/Airbus and U.S. Army).

Read the complete narrative.

Want to see what kind of revenue climb and margin shift is included in that fair value tag? The narrative focuses on sharp growth, rising profitability, and a rich future earnings multiple. Curious which assumptions carry the model and how they build up to $19.25?

Result: Fair Value of $19.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still key pressure points to watch, including Amprius' reliance on aviation and drone customers, as well as the execution risk in scaling its silicon anode manufacturing.

Find out about the key risks to this Amprius Technologies narrative.

Another View: Expensive on Sales

The DCF work suggests Amprius looks undervalued, yet the P/S ratio of 26.1x is far higher than the US Electrical industry at 2.5x, the peer average at 15.4x, and the fair ratio of 6.8x. That gap points to real valuation risk if sentiment cools.

Before leaning too heavily on headline multiples, it is worth seeing how the numbers line up in detail, then judging whether that premium feels justified for you or stretched enough to introduce downside risk on any disappointment. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals on value, growth and sentiment, it can help to move quickly and review the underlying data yourself rather than relying on any single view. To see both the potential upside and the key concerns side by side, review the 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If you want to stress test your thinking beyond Amprius, now is the moment to scan other opportunities before fresh moves and re-ratings slip past you.

• Target future compounders by reviewing screener containing 20 high quality undiscovered gems that pair strong fundamentals with quieter market attention.
• Prioritise resilience by checking 71 resilient stocks with low risk scores that score well on stability and downside protection.
• Focus on financial strength by scanning the solid balance sheet and fundamentals stocks screener (48 results) where robust balance sheets back up the story.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com